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Abstract
The in vitro differentiation of ES cells towards a hematopoietic cell fate is useful when studying cell populations that are difficult to access in vivo
and for characterizing the earliest genes involved in hematopoiesis, without having to deal with embryonic lethalities. The ES/OP9 co-culture
system was originally designed to produce hematopoietic progeny, without the over production of macrophages, as the OP9 stromal cell line is
derived from the calvaria of osteopetrosis mutant mice that lack functional M-CSF. The in vitro ES/OP9 co-culture system can be used in order to
recapitulate early hematopoietic development. When cultured on OP9 stromal cells, ES cells differentiate into Flk-1+ hemangioblasts,
hematopoietic progenitors, and finally mature, terminally differentiated lineages. The standard ES/OP9 co-culture protocol entails the placement
of ES cells onto a confluent layer of OP9 cells; as well as, periodic replating steps in order to remove old, contaminating OP9 cells. Furthermore,
current protocols involve evaluating only the hematopoietic cells found in suspension and are not optimized for evaluation of ES-derived progeny
at each day of differentiation. However, with replating steps and the harvesting of only suspension cells one potentially misses a large portion of
ES-derived progeny and developing hematopoietic cells. This issue becomes important to address when trying to characterize hematopoietic
defects associated with knockout ES lines. Here we describe a modified ES/mStrawberry OP9 co-culture, which allows for the elimination of
contaminating OP9 cells from downstream assays. This method allows for the complete evaluation of all ES-derived progeny at all days of
co-culture, resulting in a hematopoietic differentiation pattern, which more directly corresponds to the hematopoietic differentiation pattern
observed within the embryo.
Protocol
1. Preparation of ES cells
2. Preparation of OP9 cells
3. ES/mStrawberry OP9 Co-culture
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1. Culture ES cells according to standard protocol for your particular cell line. Make sure to prepare enough ES cells to plate onto of the
mStrawberry OP9 cells for Day 0 (ES cells will be plated at 1x10^3 cells per cm2 at Day 0)
1. Before growing mStrawberry OP9 cells, prepare the OP9 growth media
OP-9 Cell Culture Medium
  Stock Final conc. Volume (mL)
aMEM     39.5
FBS (OP-9 tested) 100% 20% 10
L-glutamine 100X (200mM) 2mM 0.5
      50mL
Store at 4°C and use within one week of preparation
2. In order to maintain mStrawberry OP9 cells, media must be changed every 2 days and cells should be subcultured prior to cells reaching
confluency (subculture at 70-90% confluency). mStrawberry OP9 cell cultures are never grown beyond 90 % confluency as this will result in
their differentiation into adipocytes. See Figure 3.
a. Subculture cells by washing cells 2X with PBS (or 1x with PBS + 1x 0.1% with Trypsin-EDTA)
b. Add pre-warmed 0.1% Trypsin-EDTA at 37°C for 5 minutes (or until cells detach)
c. When the cells have detached, add OP-9 growth medium. Transfer cells to a 50mL conical tube.
d. Pellet cells at 300 x g for 5 minutes at room temperature. Discard supernatant.
e. Resuspend cells in fresh mStrawberry OP9 growth media
f. Plate cells at a minimum density of 104cells/cm2
g. Grow mStrawberry OP9 cells to confluency starting 3 days prior to day needed for co-culturing ES cells (Day 0, Day 5, or Day8/9 of the
experiment)
1. Prepare Co-culture differentiation media
  Stock Final Volume (mL)4. Representative Results:
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aMEM     39.5
FBS 100% 20% 10
L-glutamine 200mM 2mM 0.5
      50mL
2. mStrawberry OP9 cells (Day –3)
a. ALWAYS Subculture OP9 cells on Day -3, so that you have confluent layers of mStrawberry OP9 cells for Day 0 of co-culture. See
Figure 4b. Plate mStrawberry OP9 cells at 1x104/cm2 for confluency at Day 0. Be sure to subculture extra cells for Day 5 and Day 8/9
for the continuation of co-culture.
3. ES/mStrawberry OP9 co-culture Set-Up (Day 0)
a. Wash ES cells 2x with PBS
b. Trypsinize ES cells with pre-warmed 0.25% Trypsin-EDTA, incubate for 5min @ 37°C
c. Add Co-culture differentiation media to cells
d. Pellet ES cells at 400xg, 5-7min, RT. Discard supernatant
e. Resuspend cells in Co-culture differentiation media
f. Remove media from mStrawberry OP9 cells
g. Add Co-culture differentiation media to mStrawberry OP9 flasks
h. Plate 1x103 ES cells/cm2 to flask of mStrawberry OP9 cells. Incubate cells at 37° C, 5% CO2 with humidity.
4. mStrawberry OP9 cells (Day 2)
a. Subculture mStrawberry OP9 so that you have confluent layers of mStrawberry OP9 cells for Day 5 of co-culture. Plate mStrawberry
OP9 cells at 1x104/cm2 for confluency at Day 5 (as in step 3.2). Be sure to subculture extra cells for Day 8/9, if necessary (as in step
2.2).
5. ES/mStrawberry OP9 co-culture (Day 3)
a. Carefully remove medium from co-culture and replace with fresh Co-culture differentiation medium
6. ES/mStrawberry OP9 co-culture (Day 5)
a. Carefully wash co-cultures 2x with PBS
b. Trypsinize cells with pre-warmed 0.25% Trypsin-EDTA
c. Wash cells off flask with Co-culture differentiation media
d. Pellet cells at 400xg, 7min, RT. Discard supernatant
e. Add Co-culture differentiation media to cells. Use a 21-gauge bluntended needle to resuspend cells and to ensure for single cell
suspension
f. Count cells using a hemocytometer. Should have 100-150 fold increase in ES cell number from Day 0.
g. Re-seed 6.48x104/cm2 – 7.76x104/cm2 co-culture cells on to a new layer of confluent, mStrawberry OP9 cells
h. Day 5 ASSAYS -Remaining co-culture cells can be used for flow cytometry analysis, cytopreps(30K cells), ChIP assays, etc.
7. ES/mStrawberry OP9 co-culture (Day 8/9 and Day 12)
a. Remove differentiation media from flask and save. Wash monolayer 1x with PBS to remove hematopoietic cells in suspension. Do not
toss out hematopoietic cells.
b. Trypsinize adherent cells with pre-warmed 0.25% Trypsin-EDTA
c. Wash cells off flask with ES differentiation media and add to hematopoietic cells found in suspension=
d. Pellet cells at 400xg, 7min, RT. Discard supernatant
e. Add Co-culture differentiation media or PBS to cells. Use a 21-gauge bluntended needle to resuspend cells and to ensure for single cell
suspension Count cells using a hemocytometer.
f. Co-culture can be continued for 14 days to evaluate more mature hematopoietic progenitors by re-seeding co-culture cells onto a new
layer of confluent, mStrawberry OP9 cells at Day 8 or 9 and then again on Day 12. Re- seed optimized cell number based on required
cell recovery for day of assay.
8. Evaluation of ES-derived progeny (Day 1-14). ES-derived progeny can be evaluated on any day of co-culture by flow sorting out mStrawberry
negative cells (ES-derived progeny).
a. Remove differentiation media from flask and save. Wash monolayer 1x with PBS to remove hematopoietic cells in suspension. Do not
toss out hematopoietic cells.
b. Trypsinize adherent cells with pre-warmed 0.25% Trypsin-EDTA
c. Wash cells off flask with Co-culture differentiation media and add to hematopoietic cells found in suspension
d. Pellet cells at 400xg, 7min, RT. Discard supernatant
e. Resuspend cells with 21-gauge bluntended needle and count
f. ES-derived progeny (mStrawberry negative cells) can be flow sorted from mStrawberry positive OP9 cells. ES-derived progeny can
then be characterized by flow cytometry analysis, cytopreps, ChIP assays, etc.Figure 1. ES/mStrawberry OP9 Co-culture System. Our lab uses an in vitro ES cell co-culture system to model hematopoietic development. In
this co-culture system, ES cells differentiate, into hemangioblasts at Day5, when placed on a confluent layer of mStrawberry OP9 cells. As the
co-culture proceeds, hematopoietic precursors are present at Day 8, while terminally differentiated hematopoietic lineages appear by Day 14.
Arrows indicate days of differentiation when passaging of ES-derived progeny onto new confluent layers of mStrawberry OP9 cells in necessary.
Figure 2. Proper ES cell Differentiation. ES cells are seeded onto a confluent layer of mStrawberry OP9 at Day 0. ES-derived progeny begin to
become visible at Day 3 of differentiation, with ES-derived progeny looking like a cluster of cells with a defined border or beginning to form a whorl
pattern. Hemangioblasts, which are the common mesodermal precursor for the endothelial and hematopoietic lineages, should appear as piled
up whorls of cells at Day 5. For co-culture periods longer than five days, ES-derived progeny should appear as clusters of hematopoietic cells.
Two to four celled clusters, at Day 6/7, should appear and grow into larger cell clusters by Day 8/9 of co-culture. Other ES derived progeny are
also found tightly bound to the adherent stromal cell layer.
Figure 3. Unsuccessful ES cell differentiation. Results from this co-culture reflect improper ES cell differentiation. Note how the ES-derived
progeny do not appear in a whorl pattern at Day 5. The absence of cells in a whorl pattern indicates improper hemangioblast formation. If
hemangioblast do not develop properly, then continued co-culture will result in stunted hematopoietic lineage differentiation. Co-cultures with
improper hemangioblast formation should be discarded.
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cells and ES-derived progeny are placed onto a overly confluent layer of mStrawberry OP9 cells.
Figure 5. Representative ES/mStrawberry OP9 Co-culture flow profile. All ES-derived progeny are mStrawberry negative cells and can be
flow sorted from the mStrawberry OP9 cells. mStrawberry negative cell gate was determined using a traditional ES/OP9 co-culture.
Discussion
Proper differentiation of ES cells on confluent layer of mStrawberry OP9 cells results in the production of Flk1+ hemangioblasts at Day 5 of
co-culture. Hemangioblasts should appear as piled up whorls of cells, as observed in Figure 1. For the remainder of the co-culture, visible
ES-derived progeny should appear as clusters of hematopoietic cells (Figure 1). At Day6/7 two to four cell clusters should appear and grow into
larger cell clusters (both adherent and in suspension) by Day 8/9 of co-culture. Other ES derived progeny are also found tightly bound within the
adherent stromal cell layer.
Although not listed in the protocol, it is critical to pre-test the FBS used in the ES growth medium, the mStrawberry OP9 growth media and the
ES/mStrawberry OP9 differentiation media. Properly tested serum should ensure proper growth of mStrawberry OP9 cells, as well as, proper
differentiation of ES cells in co-culture until Day 5 of differentiation. As an alternative or in addition to mStrawberry OP9 cells, OP9 cells can be
irradiated, at 8000 rads, prior to seeding at confluency (7.8x104 cells/cm2). Irradiation of OP9 cells allows for the elimination of repeated replating
steps, as well as, allows for almost complete elimination of old, contaminating OP9 cells from downstream assays.
OP9 cells were engineered to express mStrawberry protein by transducing OP9 cells with 3ug/mL of a lentiviral vector expressing mStrawberry
under the control of a CMV promoter (pRRLsin-CMV vector, UCLA vector core).
Standard ES/OP9 co-culture protocols entail the placement of ES cells onto a confluent layer OP9 cells, as well as, a day 5 replating step in order
to reduce old, contaminating OP9 cells from cell passage. Additionally, only hematopoietic cells found in suspension are removed for evaluation of
ES-derived progeny. However, with both a replating step and the harvesting of only suspension cells one potentially misses a substantial number
of the developing ES-derived hematopoietic cells. This issue becomes important to address when trying to characterize hematopoietic defects
associated with knockout ES lines. In order to circumvent this issue our lab used a modified co-culture, through the use of
mStrawberry-expressing OP9 cells. This assures that all ES progeny are transferred to the continued co-culture at day 5, and for the harvest of all
ES-derived progeny for downstream assays. This modification provides a useful tools in the evaluation and characterization of hematopoietic
progeny derived from both human and mouse ES lines.
This ES-mStrawberry OP9 co-culture model recapitulates the various stages primitive and definitive hematopoiesis. In studying the earliest
stages of hematopoietic development, many people use the BL-CFC(Blast-like colony forming cell) assay, which assess the development of the
hemangioblast from the ES cell. While the BL-CFC assay is a useful tool when investigating early hematopoietic development, the
mStrawberry-ES co-culture systems exhibits increase utility as it allows for the assessment of hemangioblast, as well as, more adult
hematopoietic lineages.
Previous work using traditional OP9/ES and EB differentiation protocols has shown that additional factors maybe necessary, such as
overexpression of HoxB4, in order to derive long-term repopulating hematopoietic stem cells in vitro. Additional work is necessary to assess
whether mStrawberry negative, sorted ES-derived populations contain true hematopoietic stem cells.
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